TipRanks
Advertisement
Advertisement
Kissei Pharmaceutical Reports No Treasury Share Purchases in July Under Ongoing Buyback Plan
PremiumCompany AnnouncementsKissei Pharmaceutical Reports No Treasury Share Purchases in July Under Ongoing Buyback Plan
3M ago
Kissei Pharmaceutical Cuts Earnings Forecasts on Weak TAVNEOS Sales
Premium
Company Announcements
Kissei Pharmaceutical Cuts Earnings Forecasts on Weak TAVNEOS Sales
3M ago
Kissei Pharmaceutical Highlights Q1 FY2026 Results and R&D Pipeline Focus
Premium
Company Announcements
Kissei Pharmaceutical Highlights Q1 FY2026 Results and R&D Pipeline Focus
3M ago
Kissei Faces EU Setback as EMA Backs Revocation of TAVNEOS Authorization
PremiumCompany AnnouncementsKissei Faces EU Setback as EMA Backs Revocation of TAVNEOS Authorization
4M ago
Kissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
Premium
Company Announcements
Kissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
4M ago
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
Premium
Company Announcements
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
5M ago
Kissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
PremiumCompany AnnouncementsKissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
5M ago
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
Premium
Company Announcements
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
5M ago
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
Premium
Company Announcements
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―